GleamWall
中文EN

HRTX HERON THERAPEUTICS, INC. /DE/

Pharmaceutical Preparations · Nasdaq · SEC CIK 818033 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-4.4%
TTM net income YoY-58.8%
TTM EPS YoY-22.2%
Revenue 3-yr CAGR6.5%
Net income 3-yr CAGR—

Margins

Gross margin71.5%
Operating margin-5.7%
Net margin-14.5%
FCF margin-9.7%
EBITDA margin-4.4%

Returns

ROE-217.8%
ROA-9.0%
ROIC (approx.)—
Asset turnover0.62x

Leverage & solvency

Liabilities / assets97.9%
Debt / equity0.00x
Current ratio2.33x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.64x
Accruals ratio-3.3%
Payout ratio—
Capex / revenue0.4%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$154.90M$144.28M
Cost of revenue$41.35M$38.65M
Gross profit$113.56M$105.64M
R&D expense$12.43M$16.68M
SG&A expense$54.60M$53.40M
Operating income-$2.54M-$11.53M
Interest expense$9.61M$6.03M
Income tax$0$0
Net income-$20.20M-$13.58M
EBITDA-$224,000-$9.04M
EPS (basic)-0.12-0.09
EPS (diluted)-0.12-0.09
Weighted avg. shares (diluted)166.71M152.45M
Balance sheet
Cash & equivalents$28.65M$25.80M
Short-term investments$17.98M$33.48M
Receivables$89.59M$78.88M
Inventory$92.75M$53.16M
Current assets$238.07M$209.01M
PP&E, net$12.40M$14.86M
Total assets$255.88M$233.15M
Current liabilities$96.10M$91.46M
Total liabilities$241.54M$266.80M
Shareholders' equity$14.33M-$33.65M
Shares outstanding188.31M152.13M
Cash flow statement
Operating cash flow-$27.59M-$22.53M
Capital expenditure$317,000$1.71M
Free cash flow-$27.91M-$24.23M
Investing cash flow$16.01M$18.71M
Financing cash flow$14.43M$940,000
Depreciation & amortization$2.31M$2.49M
Stock-based compensation$10.34M$12.96M

Free plan shows the latest 2 periods; Pro shows all 17 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.